Approved Hospital Formulary
Add Formweb to your mobile device
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Search results for:
ARIPiprazole
ARIPiprazole
| Drug Name | Form | Strength | Clinic Use Only | Inpatient Restrictions | Outpatient Restrictions | Non-Formulary |
|---|---|---|---|---|---|---|
| Aripiprazole | SOLUTION, ORAL | 1 mg/ml | ||||
| Abilify Maintena | SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR | 300 mg; 400mg | ||||
| Aristada | SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR | 441 mg/1.6 mL; 662 mg/2.4 mL; 882 mg/3.2 mL; 1064 mg/3.9 mL | ||||
| Aristada Initio | SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR | 675 mg/2.4 ml | ||||
| Aripiprazole | TABLET, DISINTEGRATING, ORAL | 10 mg; 15 mg | ||||
| Aripiprazole | TABLET, ORAL | 1 mg (1/2 tab); 2 mg; 2.5 mg (1/2 tab); 5 mg; 7.5 mg (1/2 tab); 10 mg; 15 mg; 30 mg | ||||
| Abilify | TABLET, ORAL | 2 mg; 5 mg; 10 mg; 15 mg; 30 mg |
VIEW MORE psychotherapeutic agents, antipsychotics, atypical antipsychotics
CLASS
CLASS
m00242, m00251, m00341
Last updated: Feb. 5, 2024
- Black Box Warning Elderly patients with dementia related psychosis
- Policy Tier 1: Long Acting Injectable Antipsychotics
**Abilify Maintena, Aristada, and Aristada Initio, are approved for use in the outpatient setting. Inpatient use restricted and must meet Tier 1 criteria**